Syros Pharmaceuticals, Inc. (SYRS) Operating Lease, Liability USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Syros Pharmaceuticals, Inc. quarterly Operating Lease, Liability history and growth rate from 2019 to 2024.
  • Syros Pharmaceuticals, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $20.3 M, a 9.3% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $20.3 M -$2.08 M -9.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $20.9 M -$2.01 M -8.77% Dec 31, 2023 10-K 2024-03-27
Q3 2023 $21.4 M -$1.93 M -8.29% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $21.9 M -$1.86 M -7.83% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $22.4 M -$1.79 M -7.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $22.9 M -$1.72 M -7% Dec 31, 2022 10-K 2023-03-02
Q3 2022 $23.3 M -$1.65 M -6.62% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $23.7 M -$1.59 M -6.27% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $24.2 M -$1.53 M -5.94% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $24.6 M -$1.46 M -5.62% Dec 31, 2021 10-K 2022-03-15
Q3 2021 $25 M -$1.4 M -5.32% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $25.3 M -$1.34 M -5.04% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $25.7 M +$161 K +0.63% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $26 M +$986 K +3.94% Dec 31, 2020 10-K 2021-03-04
Q3 2020 $26.4 M +$5.97 M +29.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $26.7 M +$8.8 M +49.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $25.5 M +$23.6 M +1205% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $25.1 M Dec 31, 2019 10-K 2020-03-05
Q3 2019 $20.4 M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $17.9 M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.96 M Mar 31, 2019 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.